Related Experiment Video
Updated: Aug 10, 2026

13:04
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
Ovarian Cancer Surgery - A Population-based Registry Study
Pia Leandersson1, Gabriel Granåsen2, Christer Borgfeldt3
1Department of Obstetrics and Gynecology, Skåne University Hospital, Lund University, Lund, Sweden.
Anticancer Research
|April 5, 2017
Summary
Tertiary centers perform more extensive ovarian cancer surgery than regional hospitals without increased complications. However, significant variations exist among tertiary centers in primary debulking surgery selection and achieving no residual tumor.
Area of Science:
- Gynecologic Oncology
- Surgical Oncology
- Clinical Outcomes Research
Background:
- Ovarian cancer surgery is a critical component of treatment.
- Evaluating surgical care quality across different healthcare settings is essential.
Purpose of the Study:
- To compare ovarian cancer surgery outcomes between tertiary centers (TC) and regional hospitals (RH).
- To assess differences in surgical approach and results within tertiary centers.
Main Methods:
- Analysis of data from the GynOp registry (2013-2015).
- Inclusion of patients undergoing surgery for ovarian cancer or borderline tumors.
- Comparison of surgical volume, patient selection, and complication rates between TC and RH.
Main Results:
- Tertiary centers performed 69.5% of surgeries, including 86.5% of advanced stage (FIGO IIIC-IV) cases.
- Significant variations (p<0.001) were observed between TC in primary debulking surgery (PDS) rates (45%-93%) and achieving no residual tumor (36%-70%).
- No significant differences in major complications, re-admissions, or re-operations were found between TC and RH.
Conclusions:
- Tertiary centers provide more extensive ovarian cancer surgery without higher complication rates.
- Significant heterogeneity exists among tertiary centers regarding PDS selection and optimal tumor debulking.
- Further investigation into TC-specific practices is warranted to optimize ovarian cancer surgical care.

